Clinical Trials Directory

Trials / Unknown

UnknownNCT02781259

Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast Cancer

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Samsung Medical Center · Academic / Other
Sex
Female
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

In this study, navigation of lymphatic passage after sentinel lymph node with indocyanine green was performed during axillary lymph node dissection in breast surgery . By comparing the concordance between the passage of indocyanine green and actual lymph node metastasis, selective lymph node dissection can be developed.

Detailed description

Low dose of indocyanine green emits near-infrared fluorescence, which can penetrate thin tissues like breast or skin. The operator can track the lymphatic pathway without skin incision in real time. By these characteristics, indocyanine green is currently used for sentinel lymph node biopsy in breast cancer surgery. Indocyanine green can also stain lymph nodes beyond the sentinel lymph nodes. This is why we can identify the lymphatic metastasis pathway of breast cancer.

Conditions

Interventions

TypeNameDescription
PROCEDUREAxillary lymph node dissectionLymph node dissection is performed in axillary lymph node level I and II. In case of palpable nodes in level II, additional lymph node dissection in level III is done.
DRUGIndocyanine green10cc of 20μg/mL indocyanine green is injected at the nipple-areola complex before surgery
DEVICEImaging devicesNear-infrared fluorescence is collected by imaging lenses and digital camera.

Timeline

Start date
2016-05-01
Primary completion
2017-02-01
Completion
2017-04-01
First posted
2016-05-24
Last updated
2016-09-20

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02781259. Inclusion in this directory is not an endorsement.